Urgent.News

What's breaking now, across hundreds of outlets.

Health & Medicine

Are GLP-1s Enabling Disordered Eating?

(MedPage Today) -- I often open my obesity medicine visits by asking "How are you feeling today?" Today the answer was, "I feel like the medication is finally working!" I checked the chart to find that the patient was down 21 pounds in 3 months...

Are GLP-1s Enabling Disordered Eating?

The use of GLP-1 medications, such as tirzepatide and semaglutide, has drastically improved the treatment efficacy for obesity. These drugs can reduce spontaneous food intake by hundreds of calories per day and lead to significant weight loss. However, this powerful medication comes with risks of over-suppression of appetite, causing some patients to engage in risky behaviors like water fasting or excessive exercise.

Patients have reported feeling "amazing" on these medications, even choosing to fast for extended periods, despite potential risks. In one case, a patient fasted for 13 days, leading to dehydration and electrolyte imbalances. Emergency visits have also resulted from fainting and head injuries due to overexertion and dehydration.

Clinicians must carefully monitor patients taking GLP-1 medications, ensuring proper hydration, nutrition, and appropriate weight loss. The recommendations include at least 60 ounces of water daily, 60 grams of protein, and 1,000 calories. Eating three healthy meals a day and avoiding fasting or overly restrictive eating regimens is advised.

For patients with a history of eating disorders or psychiatric comorbidities, extra support through cognitive behavior therapy and psychology referrals is recommended. In cases where restrictive eating and emotional eating are concerns, medications may need to be decreased or stopped. The goal is to prioritize the patient's long-term health and prevent disordered eating behaviors.

Rewritten by urgent.news; may contain errors — check the original.

Source: medpagetoday.com

Read the original at medpagetoday.com →

Report a problem with this story

More in Health & Medicine

More from Sunday 22 November →